Why write ten lines of code when one will do? From magic variable swaps to high-speed data counting, these Python snippets ...

Abstract: Building collapses, irrespective of structure type or location, result in global tragedies. Rapid rescue efforts are essential, especially within the critical three-day window for trapped ...

This is a review of Truth: What It Is, How To Find It & Why It Still Matters. by Michael Shermer, forthcoming from Johns Hopkins University Press. Amidst claims of “fake news,” “alternative facts,” ...

This video explains the history of a.m. and p.m., how they came from Latin timekeeping, and why noon and midnight are labeled differently than other hours. Two congressmen watched an ICE shooting ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Getting a handle on LeetCode can feel like a big task, especially when you’re starting out. But with the right approach and tools, it becomes much more manageable. Python, with its clear syntax and ...

Plastics are woven into every aspect of our lives, but what was once the poster child for convenience is fast becoming a pariah product. The era of single-use plastic must end; banning it is the only ...

Sometimes, reading Python code just isn’t enough to see what’s really going on. You can stare at lines for hours and still miss how variables change, or why a bug keeps popping up. That’s where a ...

Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. For its second quarter, Recursion earned $19.2 million in ...

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. This was largely due to news from a ...

In a recent social media post, Peter Ray, senior director of medicinal chemistry at Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), drew attention to a new article in WIRED from Veronique Greenwood ...